Edward P. Sloan, MD, MPH, FACEP Optimizing ED Seizure & SE Patient Management: A Useful SE Treatment Protocol.

Slides:



Advertisements
Similar presentations
ED Patient Pain Management: A 2004 Emergency Medicine Perspective.
Advertisements

Guidelines for the Evaluation and Management Status Epilepticus
J. Stephen Huff, MD, FACEP Critical Issues in the Evaluation and Management of Adult Patients Presenting to the ED with Seizures: The 2004 ACEP Clinical.
Status Epilepticus-Definition
Status Epilepticus: Clinical Features, Pathophysiology, and Treatment
Optimizing Seizure and SE Patient Management in the Emergency Department Edward P. Sloan, MD, MPH, FACEP.
Issues Surrounding the Management of Patients Who Present to the Emergency Department with Subtherapeutic Phenytoin Levels and a History of Seizures Edwin.
What is the Best Way to Provide a Phenytoin Load? Edwin Kuffner, MD Rocky Mountain Poison and Drug Center University of Colorado.
Optimizing Seizure and SE Patient Management in the Emergency Department Edward P. Sloan, MD, MPH, FACEP.
Seizures: Nuts and Bolts National Pediatric Nighttime Curriculum Written by Anna Lin, MD Lucile Packard Children’s Hospital.
Epilepsy 2 Dr. Hawar A. Mykhan.
Edward P. Sloan, MD, MPH United States Health & Human Services: Programs & Resources for Emergency Medical Services.
Edward P. Sloan, MD, MPH, FACEP Successful Grantsmanship Private Grant Writing.
Edward P. Sloan, MD, MPH, FACEP Conducting Successful EM Resident Research: Working with Databases.
Edward P. Sloan, MD, MPH, FACEP Diagnosing & Treating Emergency Department CNS Hemorrhage Patients.
What Do We Do When Benzodiazepines Fail?. Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
ED TIA Patient Case Presentation Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
ACEP Clinical Policy: Adult Headache Patients. Ponte Vedra Beach, FL June 24, Clinical Decision Making in Emergency Medicine Ponte Vedra Beach,
SeizureStat © A PDA Software for Seizure/SE Therapeutics and the 2004 ACEP Seizure Clinical Policy Edward P. Sloan, MD, MPH, FACEP Associate Professor.
Edward P. Sloan, MD, MPH, FACEP Conducting Successful EM Resident Research: Research Project Idea Generation.
Edward P. Sloan, MD, MPH ACEP Clinical Policy Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department.
Edward P. Sloan, MD, MPH FACEP ED Transient Ischemic Attack Patient Management: What Role for Outpatient Evaluation and Disposition?
Clinical Policy / Practice Guideline Development Andy Jagoda, MD, FACEP Professor of Emergency Medicine Mount Sinai School of Medicine New York, New York.
Edward P. Sloan, MD, MPH, FACEP Research Lecture Private Grant Writing.
Neurological Emergencies Dr. Amal Alkhotani MBBCH, FRCPC, Epilepsy and EEG.
Seizures: Nuts and Bolts Nightfloat Curriculum Lucile Packard Children’s Hospital Residency Program.
Edward P. Sloan, MD, MPH FERNE/MEMC Session: Optimal Treatment of Neurological Emergencies Patients.
The Management of Seizures and SE in the Emergency Department.
Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures Andy Jagoda, MD, FACEP Professor of Emergency.
Status Epilepticus (SE): Rx Following Benzodiazepine Use Edward Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois.
Clinical Policies’ Development and Applications Andy Jagoda, MD Professor of Emergency Medicine Mount Sinai School of Medicine New York, NY Critical Issues.
Managing Seizure Patients in SE Following the Use of the Benzodiazepines.
The 2004 ACEP Seizure Clinical Policy: The 2004 ACEP Seizure Clinical Policy: What About Pediatric Seizure and Status Epilepticus Patients? John M. Howell,
Edward P. Sloan, MD, MPH, FACEP The Management of ED Seizure and Status Epilepticus Patients: The Role of 1st & 2nd Generation Anti-epileptic Drugs in.
How Do We Evaluate, Treat, and Disposition New Onset Seizure Patients? Andy Jagoda, MD, FACEP Professor of Emergency Medicine Mount Sinai School of Medicine.
Optimizing Seizure and SE Patient Management in the Emergency Department Edward P. Sloan, MD, MPH, FACEP.
First Line Therapy in Acute Seizure Management William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert Wood Johnson University Hospital.
Pediatric Prehospital Seizure Management: Evidence Based Guidelines and State of Care in CO Kathleen Adelgais, MD MPH Pediatric Emergency Medicine Children’s.
Optimal Pain Management for ED Patients: Issues in 2004 Edward P. Sloan, MD, MPH, FACEP Professor Department of Emergency Medicine University of Illinois.
How Do We Treat SE Patients When the Benzodiazepines Fail?
Edward P. Sloan, MD, MPH, FACEP ED Neurological Emergencies Patients’ Neuroresuscitation Update: Seizure & Status Epilepticus Management Procedure.
Edward P. Sloan, MD, MPH, FACEP Conducting Successful EM Resident Research: Generating Research Ideas and Hypotheses.
Edward P. Sloan, MD, MPH MEMC Session Using the Internet to Improve the Care of Neurological Emergencies Patients.
The ED Treatment of Seizure and SE Patients: What the 2004 ACEP Seizure Clinical Policy Doesn’t Tell You 1 Edward P. Sloan, MD, MPH, FACEP.
Andy S. Jagoda, MD 1 Seizure and Status Epilepticus Therapeutics: A 2005 Update.
Edward P. Sloan, MD, MPH, FACEP Emergency Department Patient Hypertensive Emergencies: Published Guidelines, Articles, & Their Findings.
“Six Publications That Influence Neurological Emergency Patient Resuscitation in 2010”
Adult Seizure and SE Patient ED Care: Crossfire Edward P. Sloan, MD, MPH, FACEP 1.
Benzodiazepines What are the Best Non-IV Parenteral Options for a Seizing Patient? William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert.
Edward P. Sloan, MD, MPH 1 st and 2 nd Generation Antiepileptic Drug Use in the ED: Optimal 2007 Strategies.
Acute Ischemic Stroke Management: 2004 Emergency Medicine Perspectives.
Managing and Detecting Seizures in the ICU Special thanks to: Katherine Nickels, MD Assistant Professor of Neurology and Pediatrics Mayo Clinic.
ACEP Clinical Policy: ACEP Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures William C. Dalsey,
Edward P. Sloan, MD, MPH, FACEP Diagnosing & Treating ED CNS Hemorrhage Patients.
Edward P. Sloan, MD, MPH, FACEP Putting it All Together with Seizure Clinical Policies: Making Good Clinical Decisions & Improving ED Seizure Patient Care.
J. Stephen Huff, MD 1 What the ACEP Seizure Clinical Policy Doesn’t Tell Us about Adult Seizure and Status Epilepticus Patients… What the ACEP Seizure.
Edward P. Sloan, MD, MPH, FACEP Basic Statistics for EM Research: Power Calculations.
Edward P. Sloan, MD, MPH, FACEP Optimizing Seizure and SE Patient Management: Seizure Therapies Workshop and Clinical Policy Review.
Edward P. Sloan, MD, MPH EMRA/FERNE Neurological Emergencies Case Conference Special Panel Discussion: Tell me One Thing About Emergency Medicine.
Status epilepticus. Status Epilepticus Traditionally, SE is defined as continuous or repetitive seizure activity persisting for at least 30 minutes without.
Research Design: The Progression of Study Designs that Address a Clinical Question.
Jason Haag Intern Conference. Case 34 y.o. with h/o seizure disorder presents to ED with increased seizure frequency. He states he’s had 4 tonic-clonic.
Status Epilepticus Maria B. Weimer, MD LSUHSC Neurology.
Management. Goals of emergency management for status epilepticus Ensure adequate brain oxygenation and cardiorespiratory function Terminate clinical and.
Edward P. Sloan, MD, MPH Optimizing Seizure and SE Patient Management in the Emergency Department.
Managing Seizure Patients in SE Following the Use of the Benzodiazepines.
First Line Therapy in Acute Seizure Management: Focusing on the Pediatric Patient William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert.
Edward P. Sloan, MD, MPH Grant Opportunities in Emergency Medical Services & Bioterrorism Preparedness.
New Onset Seizures in the Adult Andy Jagoda, MD, FACEP Professor of Emergency Medicine Mount Sinai School of Medicine New York, New York.
Edward P. Sloan, MD, MPH Optimizing Seizure and SE Patient Management: Seizure Therapies Workshop and Clinical Policy Review.
Presentation transcript:

Edward P. Sloan, MD, MPH, FACEP Optimizing ED Seizure & SE Patient Management: A Useful SE Treatment Protocol

Edward P. Sloan, MD, MPH, FACEP Edward Sloan, MD, MPH Professor Department of Emergency Medicine University of Illinois College of Medicine Chicago, IL

Edward P. Sloan, MD, MPH, FACEP Attending Physician Emergency Medicine Attending Physician Emergency Medicine University of Illinois Hospital Our Lady of the Resurrection Hospital Chicago, IL

Edward P. Sloan, MD, MPH, FACEP Global Objectives Improve pt outcome in seizures and SE Know how to quickly evaluate seizing pts Know clinically how to use protocols Provide rationale ED use of AEDs Facilitate useful disposition, documentation Improve Emergency Medicine practice

Edward P. Sloan, MD, MPH, FACEP Session Objectives Present a relevant patient case Discuss key clinical questions State key learning points Review the procedure of SE management Evaluate the patient outcome and ED documentation

Edward P. Sloan, MD, MPH, FACEP A Clinical Case

Edward P. Sloan, MD, MPH, FACEP Patient Clinical History 37 yo male EMS to ED Generalized seizure at home, CFD: IV diazepam, resolved Hx TBI (remote) as seizure etiology On Phenobarbital and Dilantin Non-compliant in past No recent illness

Edward P. Sloan, MD, MPH, FACEP ED Presentation Post-ictal in ED Non-focal neurological exam No evidence of trauma or toxicity More appropriate, answers OK Pt then has a recurrent generalized seizure Is this patient an outlier? What is his optimal management?

Edward P. Sloan, MD, MPH, FACEP Why Do This Exercise? Status epilepticus is a medical emergency Few hospitals utilize a SE protocol A SE protocol improves patient outcome Guidelines exist that facilitate practice These efforts improve patient care, minimize risk, and enhance clinical practice

Edward P. Sloan, MD, MPH, FACEP Key Clinical Questions What are the key diagnostic issues? How can ED patient Rx be optimized? What guidelines direct our therapy? What drugs must be available for use? How can these drugs best be used? Over what time period should SE Rx occur? How should this SE Rx be documented?

Edward P. Sloan, MD, MPH, FACEP ED Seizure/SE Patients: Key Clinical Concepts

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Pathophysiology

Edward P. Sloan, MD, MPH, FACEP Status Epilepticus Seizure > minutes Two seizures, no lucid interval Assumes ongoing seizure activity when unresponsive

Edward P. Sloan, MD, MPH, FACEP SE Pathophysiology Early compensation meets increased CNS metabolic needs (SBP, CBF ↑↑) Failure at min, (SBP, CBF ↓↓) CNS tissue necrosis, morbidity

Edward P. Sloan, MD, MPH, FACEP SE Pathophysiology Glutamate toxic mediator CNS necrosis even if systemic complications fully treated HTN, fever, rhabdomyolysis, hypercarbia, hypoxia, infection

Edward P. Sloan, MD, MPH, FACEP AMS in Seizures/SE Mental status should improve by minutes If pt remains comatose, consider subtle SE & EEG Up to 20% of comatose seizure pts are in subtle SE

Edward P. Sloan, MD, MPH, FACEP Two Non-GCSE Types Non-convulsive SE: –Absence SE –Complex-partial SE Subtle SE: –Late generalized convulsive SE –Coma, persistent ictal discharge –Very grave prognosis

Edward P. Sloan, MD, MPH, FACEP Subtle SE Severe insult, ie hypoxic Comatose Limited motor activity Mortality exceeds 50% Stop the seizure EEG confirmation

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Treatment Protocols

Edward P. Sloan, MD, MPH, FACEP SE Protocols Few published protocols Fewer studied protocols Limited evidence for single approach No other supporting data for one way Internet protocols exist Similar AEDs utilized Protocols provide guidance

Edward P. Sloan, MD, MPH, FACEP VA Coop Study Treiman, NEJM 1998 Four treatments, 20 min endpoint GCSE, non-convulsive SE terminated Lorazepam 65%, phenobarbital 58% Diazepam and phenytoin 56% Phenytoin alone inferior 44% No use of fosphenytoin

Edward P. Sloan, MD, MPH, FACEP SE Review Article Lowenstein, NEJM 1998 Timed AED therapy Lorazepam, a phenytoin, phenobarbital Midazolam or propofol infusion IV valproate not included in protocol Pentobarbital not an ED drug EMS: IM midazolam

Edward P. Sloan, MD, MPH, FACEP Pediatric SE Protocol Status Epilepticus Working Party British protocol, Arch Dis Child, 2000 Lorazepam, a phenytoin, paraldehyde General anesthesia Phenobarbital, IV valproate not included No clear relationship to US practice Adult SE protocol applies in US

Edward P. Sloan, MD, MPH, FACEP ACEP Seizure/SE Clinical Policy

Edward P. Sloan, MD, MPH, FACEP Evidence Strength Strength (Class) of evidence –I: Randomized, double blind interventional studies for therapeutic effectiveness; prospective cohort for diagnostic testing or prognosis –II: Retrospective cohorts, case control studies, cross-sectional studies –III: Observational reports; consensus reports Evidence strength downgraded if flawed methodologically

Edward P. Sloan, MD, MPH, FACEP Recommendation Strength Strength of recommendations: – A (Standard): High degree of certainty based on Class I studies – B (Guideline): Moderate clinical certainty based on Class II studies – C (Option): Inconclusive certainty based on Class III evidence, consensus

Edward P. Sloan, MD, MPH, FACEP Sz/SE: Phenytoin Loading What are effective phenytoin dosing strategies for preventing seizure recurrence in patients who present to the ED with a sub-therapeutic serum phenytoin level? (outcome measure: short term seizure recurrence)

Edward P. Sloan, MD, MPH, FACEP Sz/SE: Phenytoin Loading Level C recommendation: −Administer an intravenous or oral loading dose of phenytoin or intravenous or intramuscular fosphenytoin, and restart daily oral maintenance dosing.

Edward P. Sloan, MD, MPH, FACEP Sz/SE SE Therapeutics What agent(s) should be administered to a patient in status who continues to seize despite a loading dose of a benzodiazepine and a phenytoin? (outcome measure: cessation of motor activity)

Edward P. Sloan, MD, MPH, FACEP Sz/SE SE Therapeutics Level C recommendation: –Administer one of the following agents intravenously: “high-dose phenytoin,” phenobarbital, valproic acid, midazolam infusion, pentobarbital infusion, or propofol infusion.

Edward P. Sloan, MD, MPH, FACEP Sz/SE: EEG Monitoring When should an EEG be performed in the ED?

Edward P. Sloan, MD, MPH, FACEP Sz/SE: EEG Monitoring Level C recommendation: –Consider an emergent EEG for patients suspected of being in non-convulsive SE or in subtle convulsive SE, for patients who have received a long-acting paralytic, or for patients who are in a drug-induced coma.

Edward P. Sloan, MD, MPH, FACEP SeizureStat ©

Edward P. Sloan, MD, MPH, FACEP Using SeizureStat© FERNE software Provides various data –Written seizure/SE information –Therapies for urgent ED use –ACEP clinical policy recommendations Free from websitewww.ferne.org

Edward P. Sloan, MD, MPH, FACEP A Perspective on Procedures Critically ill ED patients A medical emergency Limited time and resources A need to act “Emergency physicians take a surgeon’s approach to medical emergencies.” We do procedures

Edward P. Sloan, MD, MPH, FACEP ED Seizure/SE Therapy: The Procedure

Edward P. Sloan, MD, MPH, FACEP Driving Principles Diagnose SE and subtle SE Stop the seizure, minimize complications Use a benzodiazepine and a phenytoin Consider valproate if pt on PO Depakote Consider the use of phenobarbital Be able to infuse midazolam or propofol Get an EEG with persistent coma

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Evaluate globally all resuscitation needs

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Evaluate globally all resuscitation needs Administer a benzodiazepine x 4 –Diazepam 5 mg q 2-5 min –Lorazepam 2 mg q 2-5 min –Midazolam 2-5 mg q 2-5 min

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Evaluate globally all resuscitation needs Administer a benzodiazepine x 4 –Diazepam 5 mg q 2-5 min –Lorazepam 2 mg q 2-5 min –Midazolam 2-5 mg q 2-5 min Order a fosphenytoin bolus infusion

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Infuse fosphenytoin 1 gr PE in 7-10 min

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Infuse fosphenytoin 1 gr PE in 7-10 min Repeat fosphenytoin 1 gr infusion

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Infuse fosphenytoin 1 gr PE in 7-10 min Repeat fosphenytoin 1 gr infusion Order an IV valproate infusion

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Infuse fosphenytoin 1 gr PE in 7-10 min Repeat fosphenytoin 1 gr infusion Order an IV valproate infusion Infuse IV valproate 1500 mg over 5 min

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Infuse fosphenytoin 1 gr PE in 7-10 min Repeat fosphenytoin 1 gr infusion Order an IV valproate infusion Infuse IV valproate 1500 mg over 5 min Order phenobarbital for bolus infusion

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Infuse fosphenytoin 1 gr PE in 7-10 min Repeat fosphenytoin 1 gr infusion Order an IV valproate infusion Infuse IV valproate 1500 mg over 5 min Order phenobarbital for bolus infusion Infuse phenobarbital mg q5 min x 5

Edward P. Sloan, MD, MPH, FACEP Seizure/SE Rx Procedure Prepare for endotracheal intubation Prepare to infuse midazolam or propofol Complete a head CT Consult a neurologist for EEG monitoring Disposition to the ICU Document the SE therapy, complications, and expected outcome

Edward P. Sloan, MD, MPH, FACEP ED Treatment and Patient Outcome

Edward P. Sloan, MD, MPH, FACEP ED Patient Management Lorazepam 2 mg IVP x 6 over 25 min “I think the IV is out…” Generalized seizure continues IV access re-established Fosphenytoin 1 gram PE over 10 min Fosphenytoin 500 mg PE over 5 min Seizure ended, pt remained obtunded

Edward P. Sloan, MD, MPH, FACEP ED Diagnostic Evaluation Non-contrast CT negative Metabolic tests normal Toxicology screening negative Sub-therapeutic phenytoin level Sub-therapeutic phenobarbital level Diagnosis: Status Epilepticus

Edward P. Sloan, MD, MPH, FACEP Patient Outcome EEG in ICU, within 120 minutes Neuro consultation, no subtle SE Patient awoke completely in 12 hours Discharged from the ICU the next day No morbidity related to SE Discharged home two days later Told to take his meds as prescribed Neurology follow-up one week later

Edward P. Sloan, MD, MPH, FACEP ED Seizure & SE Patient Rx: A Retrospective

Edward P. Sloan, MD, MPH, FACEP ED SE Patient Rx Timeline 0-20 min: ABCs, benzodiazepines min: Phenytoins min: Phenobarbital/valproate min: Midazolam/propofol min: CT, Neurology, EEG, ICU

Edward P. Sloan, MD, MPH, FACEP Questions?? Edward Sloan, MD, MPH Questions?? Edward Sloan, MD, MPH Ferne_2005_ieme_sloan_szse_fshow.ppt 8/6/ :01 PM